ARYC Stock Overview
Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Arrayit Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | -99.00% |
3 Month Change | -99.00% |
1 Year Change | 0% |
3 Year Change | -99.92% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
ARYC | US Life Sciences | US Market | |
---|---|---|---|
7D | -99.0% | -1.9% | 0.6% |
1Y | 0% | 3.9% | 29.5% |
Return vs Industry: ARYC underperformed the US Life Sciences industry which returned 3.9% over the past year.
Return vs Market: ARYC underperformed the US Market which returned 29.5% over the past year.
Price Volatility
ARYC volatility | |
---|---|
ARYC Average Weekly Movement | n/a |
Life Sciences Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ARYC's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ARYC's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Rene Schena | https://www.arrayit.com |
Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others.
Arrayit Corporation Fundamentals Summary
ARYC fundamental statistics | |
---|---|
Market cap | US$1.13k |
Earnings (TTM) | -US$6.53m |
Revenue (TTM) | US$2.82m |
0.0x
P/S Ratio0.0x
P/E RatioIs ARYC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ARYC income statement (TTM) | |
---|---|
Revenue | US$2.82m |
Cost of Revenue | US$1.43m |
Gross Profit | US$1.39m |
Other Expenses | US$7.92m |
Earnings | -US$6.53m |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did ARYC perform over the long term?
See historical performance and comparison